Dr. Sana Hosseini is a Principal Engineer at Aptar Pharma’s clinical manufacturing facility in New Jersey, where she leads CMC programs from development through clinical manufacturing for a diverse portfolio of clients. She earned her Ph.D. in Mechanical and Nuclear Engineering from Virginia Commonwealth University in 2021, where her graduate research received several academic awards. In her current role, Dr. Hosseini collaborates closely with cross-functional teams to identify technical risks early, develop integrated strategies, and drive programs efficiently toward clinical milestones. She also leads R&D initiatives to advance scalable product development capabilities and particle engineering platforms.
Prior to joining Aptar, Dr. Hosseini held senior technical roles at global pharmaceutical CDMOs, where she led development programs for inhaled therapeutics across multiple modalities. Her experience spans early feasibility, formulation and process development, scale-up, and clinical manufacturing. Dr. Hosseini has been a member of IPAC-RS since 2022 and contributes to cross-company collaboration within the OINDP community. She is also engaged in mentorship, talent development, and peer review for scientific journals, including Int. J. Pharmaceutics and J. Aerosol Sci.
